- Lobbying
- Lobbying by QRxPHARMA LIMITED
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
JILL HOMER STEWART | Rep. Peter Visclosky - Legislative Director |
" " | Rep. Robert Weygand, Staff Assistant Sen. Dianne Feinstein, Staff Assistant Rep. Gary Condit, Intern Rep. Joe Walsh - Legislative Assistant |
WILLIAM CRONIN | Sen. George LeMieux - Correspondence Manager |
FRANKIE L. TRULL | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Improved post-surgical pain medication.
Prescription drug abuse deterent technology..
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Improved post-surgical pain medication.
Prescription drug abuse deterent technology..
Termination
Q1 Report
Q4 Report
Q3 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Q2 Report
Lobbying Issues
Agencies Lobbied
U.S. House of Representatives
Natl Institutes of Health (NIH)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Licensing from NIH/OTT of existing drug compound for treatment of acute mental depression and post-traumatic stress disorder..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate